60 Degrees Pharmaceuticals (SXTP) Payables (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Payables of $1.9 million for Q1 2026, up 4.08% year-over-year from $1.8 million in Q1 2025, and up 1.79% quarter-over-quarter from $1.8 million in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Payables (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Payables for 5 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables rose 4.08% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (up 4.08% YoY), while the FY2025 annual figure was $1.8 million, up 11.26% from the prior year.
- Payables rose to $1.9 million in Q1 2026 per SXTP's latest filing, from $1.8 million in the prior quarter.
- Across five years, Payables topped out at $2.8 million in Q4 2023 and bottomed at $1.1 million in Q1 2024.
- Historically, Payables has averaged $1.8 million across 5 years, with a median of $1.8 million in 2025.
- Annual changes were most pronounced in 2023 — Payables soared 110.42% — and 2024, when it plunged 46.79%.
- 60 Degrees Pharmaceuticals' Payables stood at $1.3 million in 2022, then surged by 110.42% to $2.8 million in 2023, then slumped by 41.4% to $1.6 million in 2024, then advanced by 11.26% to $1.8 million in 2025, then grew by 1.79% to $1.9 million in 2026.
- Business Quant data shows SXTP's Payables at $1.9 million in Q1 2026, $1.8 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.87 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 2.19 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 2.81 Mn |
| Sep 30, 2023 | 2.45 Mn |
| Jun 30, 2023 | 2.16 Mn |
| Dec 31, 2022 | 1.34 Mn |